• In the media
  • Save the Children welcomes the Access to Vacc...
Media - published on 06 Mar 2017

Save the Children welcomes the Access to Vaccines Index

Save the Children welcomes the first Access to Vaccines Index as a new catalyst to stimulate action from pharmaceutical companies to improve access to vaccines and open a dialogue among all stakeholders to ensure that vaccine prices are not a barrier to reaching every last child

In a blog post, Kirsten Mathieson, Senior Health Policy & Research Adviser at Save the Children, refers to the Index as a “new tool to transparently measure the efforts of pharmaceutical companies."

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |